HealthWarehouse.com Reports Results for Second Quarter 2026
Strategic Partnership Accelerates Integration of Artificial Intelligence Across Operations
The Company reported a net loss of
HealthWarehouse.com, a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). HealthWarehouse.com provides a platform focused on increasing access to and reducing costs of healthcare products for consumers and business partners nationwide.
Joseph Peters, President and CEO, commented, “Our revenue continued to reflect the impact of the FDA’s curtailment of production and sales of compounded GLP-1 medications in early 2025, which had met a shortfall in supply while brand-name manufacturers increased production capacity to meet strong demand. At the same time, we continue to expand our offerings through new business units and strategic partnerships that are helping to offset this impact. Our scalable platform, combined with world-class customer service, positions us to capitalize on these growth opportunities and continue delivering value to our partners and customers.”
HealthWarehouse.com continues to invest in proprietary technology to remain at the forefront of new developments and offerings in the world of healthcare, focusing on customer experience, operational efficiency, and scalability. Through its strategic partnership with healthwords.ai, one of the world’s leading healthcare focused artificial intelligence companies, the Company has begun to integrate artificial intelligence tools into its operating software to improve efficiency and scalability.
“Our partnership with healthwords.ai is already beginning to deliver meaningful benefits by leveraging artificial intelligence to streamline operations, improve efficiency, and identify new opportunities across our business. We are excited about the next phase of the partnership, which will focus on expanding the practical applications of AI throughout the Company and on further strengthening our operations,” said Peters. “We believe AI can be a powerful tool to help us operate more efficiently and better serve our customers. At the same time, technology will never replace the expertise, creativity, judgment, and commitment of our employees. Our people are at the heart of the world-class service that differentiates HealthWarehouse.com. We see AI as an opportunity to empower our team by reducing manual work, enabling employees to focus on higher-value activities and innovation, and by helping us build a more efficient, agile, and customer-focused company that delivers long-term value to our customers, partners, and shareholders.”
Overview of Results for Three and Six Months Ended June 30, 2026
Net Sales: Total net sales for the three and six months ended June 30, 2025, were
Prescription sales were
Sales of over-the-counter products were
Gross Profit: Gross profit for the three and six months ended June 30, 2026, was
Operating Expenses: Selling, general and administrative expenses were
Net Income and Adjusted EBITDA: The Company reported net losses of
Earnings before interest, taxes, depreciation and amortization (“EBITDA”), as adjusted for stock-based compensation and certain non-recurring charges (“Adjusted EBITDA”), were negative
| HEALTHWAREHOUSE.COM, INC. AND SUBSIDIARIES | |||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) | |||||||||||||||
| For the Three Months Ended | For the Six Months Ended | ||||||||||||||
| June 30, | June 30, | ||||||||||||||
2026 |
2025 |
2026 |
2025 |
||||||||||||
| In thousands | |||||||||||||||
| Net sales | $ |
6,133 |
|
$ |
15,706 |
|
$ |
12,480 |
|
$ |
30,743 |
|
|||
| Cost of sales |
|
2,783 |
|
|
10,541 |
|
|
5,825 |
|
|
21,034 |
|
|||
| Gross profit |
|
3,350 |
|
|
5,165 |
|
|
6,655 |
|
|
9,709 |
|
|||
| Selling, general and administrative expenses |
|
3,710 |
|
|
4,846 |
|
|
7,328 |
|
|
9,127 |
|
|||
| Net income (loss) from operations |
|
(360 |
) |
|
319 |
|
|
(673 |
) |
|
582 |
|
|||
| Interest expense |
|
(54 |
) |
|
(8 |
) |
|
(102 |
) |
|
(31 |
) |
|||
| Income (loss) before taxes |
|
(414 |
) |
|
311 |
|
|
(775 |
) |
|
551 |
|
|||
| Income tax expense |
|
- |
|
|
(83 |
) |
|
- |
|
|
(145 |
) |
|||
| Net income (loss) |
|
(414 |
) |
|
228 |
|
|
(775 |
) |
|
406 |
|
|||
| Preferred stock: | |||||||||||||||
| Series B convertible contractual dividends |
|
(86 |
) |
|
(86 |
) |
|
(171 |
) |
|
(171 |
) |
|||
| Net income (loss) attributable to common stockholders | $ |
(500 |
) |
$ |
142 |
|
$ |
(946 |
) |
$ |
235 |
|
|||
| Per share data: | |||||||||||||||
| Net income (loss) - basic | $ |
(0.01 |
) |
$ |
0.00 |
|
$ |
(0.01 |
) |
$ |
0.01 |
|
|||
| Net income (loss) - diluted | $ |
(0.01 |
) |
$ |
0.00 |
|
$ |
(0.01 |
) |
$ |
0.00 |
|
|||
| Series B convertible contractual dividends | $ |
(0.00 |
) |
$ |
(0.00 |
) |
$ |
(0.00 |
) |
$ |
(0.00 |
) |
|||
| Net income (loss) attributable to common stockholders - basic | $ |
(0.01 |
) |
$ |
0.00 |
|
$ |
(0.02 |
) |
$ |
0.00 |
|
|||
| Net income (loss) attributable to common stockholders - diluted | $ |
(0.01 |
) |
$ |
0.00 |
|
$ |
(0.02 |
) |
$ |
0.00 |
|
|||
| Weighted average common shares outstanding - basic |
|
57,169 |
|
|
56,266 |
|
|
57,044 |
|
|
56,078 |
|
|||
| Weighted average common shares outstanding - diluted |
|
57,169 |
|
|
94,129 |
|
|
57,044 |
|
|
93,423 |
|
|||
Use of Non-GAAP Financial Measures
HealthWarehouse.com, Inc. (the "Company") prepares its consolidated financial statements in accordance with the United States’ generally accepted accounting principles ("GAAP"). In addition to disclosing financial results prepared in accordance with GAAP, the Company discloses information regarding EBITDA and Adjusted EBITDA, which are commonly used. In addition to adjusting net income or net loss to exclude interest, taxes, depreciation and amortization, including amortization of right of use lease asset, (“EBITDA”), Adjusted EBITDA also excludes stock-based compensation, and certain nonrecurring charges. EBITDA and Adjusted EBITDA are not measures of performance defined in accordance with GAAP. However, Adjusted EBITDA is used internally in planning and evaluating the Company`s performance. Accordingly, management believes that disclosure of this metric offers lenders and other shareholders an additional view of the Company`s operations that, when coupled with GAAP results, provides a more complete understanding of the Company’s financial results.
Adjusted EBITDA should not be considered as an alternative to net income, net loss, or to net cash provided by or used in operating activities, as a measure of operating results or of liquidity. It may not be comparable to similarly titled measures used by other companies, and it excludes financial information that some may consider important in evaluating the Company`s performance.
Reconciliation of Net Loss (GAAP) to Adjusted EBITDA (Non-GAAP)
| Three Months Ended | Six Months Ended | |||||||||||||
| June 30, | June 30, | |||||||||||||
| (Unaudited) | 2026 |
2025 |
2026 |
2025 |
||||||||||
| In thousands | ||||||||||||||
| Net income (loss) | $ |
(415 |
) |
$ |
228 |
$ |
(775 |
) |
$ |
406 |
||||
| Interest expense |
|
54 |
|
|
8 |
|
103 |
|
|
31 |
||||
| Depreciation and amortization |
|
132 |
|
|
126 |
|
263 |
|
|
251 |
||||
| Income tax expense |
|
- |
|
|
83 |
|
- |
|
|
145 |
||||
| EBITDA (non-GAAP) |
|
(229 |
) |
|
445 |
|
(409 |
) |
|
833 |
||||
| Adjustments to EBITDA: | ||||||||||||||
| Stock-based compensation |
|
144 |
|
|
164 |
|
297 |
|
|
336 |
||||
| Adjusted EBITDA | $ |
(85 |
) |
$ |
609 |
$ |
(112 |
) |
$ |
1,169 |
||||
About HealthWarehouse.com
HealthWarehouse.com, Inc. (OTCQB: HEWA), a technology company with a focus on healthcare e-commerce, sells and delivers prescription and over-the-counter medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (“NABP”). HealthWarehouse.com provides a platform focused on increasing access and reducing costs of healthcare products for consumers and business partners nationwide. Based in Florence, Kentucky, the Company operates America's Leading Online Pharmacy and is a pioneer in affordable healthcare. As one of the first Approved Digital Pharmacies by the National Association of Boards of Pharmacy, HealthWarehouse.com services the mission of providing affordable healthcare and incredible patient services to help Americans. Learn more at www.HealthWarehouse.com.
Forward-Looking Statements
This announcement and the information incorporated by reference herein contain “forward-looking statements” as defined in federal securities laws, including but not limited to Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, which statements are based on our current expectations, estimates, forecasts and projections. Statements that are not historical facts, including statements about the beliefs, expectations and future plans and strategies of the Company, are forward-looking statements. Actual results may differ materially from those expressed in forward-looking statements or in management's expectations. Important factors which could cause or contribute to actual results being materially and adversely different from those described or implied by forward looking statements include, among others, risks related to competition, management of growth, access to sufficient capital to fund our business and our growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, cyber-attacks, access to sufficient inventory, government regulation and taxation and fraud. More information about factors that potentially could affect HealthWarehouse.com's financial results is included in HealthWarehouse.com's audited Annual Reports and Quarterly Reports available at otcmarkets.com and its prior filings with the Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260813375323/en/
Dan Seliga, Chief Financial Officer, (800) 748-7001
Source: HealthWarehouse.com, Inc.